相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer
Patrick Teoule et al.
DIGESTIVE SURGERY (2015)
Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer
Debora de Melo Gagliato et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic Factors for Postoperative Morbidity and Tumour Response After Neoadjuvant Chemoradiation Followed by Resection for Rectal Cancer
Annefleur E. M. Berkel et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Impact of Neoadjuvant Chemotherapy on Immediate Breast Reconstruction: A Meta-Analysis
Junlong Song et al.
PLOS ONE (2014)
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
Ilenia Segatto et al.
ONCOTARGET (2014)
Impact of Chemotherapy Sequencing on Local-Regional Failure Risk in Breast Cancer Patients Undergoing Breast-Conserving Therapy
Elizabeth A. Mittendorf et al.
ANNALS OF SURGERY (2013)
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni et al.
LANCET ONCOLOGY (2012)
Impact of Chemotherapy on Postoperative Complications After Mastectomy and Immediate Breast Reconstruction
Anne Warren Peled et al.
ARCHIVES OF SURGERY (2010)
Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
Michael Untch et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer:: Phase III randomized GeparTrio trial
Gunter von Minckwitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: A negative outcome study by the Spanish breast cancer research group (GEICAM)
Carlos Jara Sanchez et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?: Results of the Danish Breast Cancer Cooperative Group (DBCG)
S Cold et al.
BRITISH JOURNAL OF CANCER (2005)
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer:: The GEPARDUO Study of the German Breast Group
G von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
D Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Does timing of adjuvant chemotherapy for early breast cancer influence survival?
C Shannon et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
